Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis
Introduction Outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection in patients with pre-existing idiopathic pulmonary fibrosis (IPF) remain …
infection in patients with pre-existing idiopathic pulmonary fibrosis (IPF) remain …
Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study
Background There are few data on severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2)(COVID-19) infection in patients with idiopathic pulmonary fibrosis (IPF). The …
CoV-2)(COVID-19) infection in patients with idiopathic pulmonary fibrosis (IPF). The …
Pulmonary fibrosis: A short-or long-term sequelae of severe COVID-19?
Z Zheng, F Peng, Y Zhou - Chinese Medical Journal Pulmonary and …, 2023 - mednexus.org
The pandemic of coronavirus disease 2019 (COVID-19), caused by a novel severe acute
respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has caused an enormous …
respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has caused an enormous …
Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study
TM Drake, AB Docherty, EM Harrison… - American journal of …, 2020 - atsjournals.org
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung
disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD …
disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD …
Association between COVID-19 infection and pulmonary fibrosis: A nested case-control study
R Najjar-Debbiny, O Barnett-Griness, J Khoury… - The American Journal of …, 2023 - Elsevier
Background Pulmonary fibrosis is associated with significant morbidity. Data are scarce on
the link between coronavirus disease (COVID-19) and pulmonary fibrosis. We aimed to …
the link between coronavirus disease (COVID-19) and pulmonary fibrosis. We aimed to …
[HTML][HTML] Characteristics and prognostic factors of pulmonary fibrosis after COVID-19 pneumonia
E Cocconcelli, N Bernardinello, C Giraudo… - Frontiers in …, 2022 - frontiersin.org
Background Few is known about the long-term pulmonary sequelae after COVID-19
infection. Hence, the aim of this study is to characterize patients with persisting pulmonary …
infection. Hence, the aim of this study is to characterize patients with persisting pulmonary …
Risk factors for mortality after COVID-19 in patients with preexisting interstitial lung disease
Patients with preexisting interstitial lung disease (ILD) may be at high risk for severe
coronavirus disease (COVID-19) because of impaired lung function, propensity to develop …
coronavirus disease (COVID-19) because of impaired lung function, propensity to develop …
[HTML][HTML] Idiopathic pulmonary fibrosis and post-COVID-19 lung fibrosis: links and risks
F Patrucco, P Solidoro, F Gavelli, D Apostolo, M Bellan - Microorganisms, 2023 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is considered the paradigmatic example of chronic
progressive fibrosing disease; IPF does not result from a primary immunopathogenic …
progressive fibrosing disease; IPF does not result from a primary immunopathogenic …
[HTML][HTML] Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review
S Duong-Quy, T Vo-Pham-Minh, Q Tran-Xuan… - Pulmonary …, 2023 - Springer
Patients with coronavirus disease 2019 (COVID-19) usually suffer from post-acute sequelae
of coronavirus disease 2019 (PASC). Pulmonary fibrosis (PF) has the most significant long …
of coronavirus disease 2019 (PASC). Pulmonary fibrosis (PF) has the most significant long …
[HTML][HTML] Post–coronavirus disease 2019 pulmonary fibrosis: wait or needs intervention
HY Yoon, ST Uh - Tuberculosis and Respiratory Diseases, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) has become a major health burden
worldwide, with over 450 million confirmed cases and 6 million deaths. Although the acute …
worldwide, with over 450 million confirmed cases and 6 million deaths. Although the acute …
相关搜索
- covid 19 lung disease
- covid 19 pulmonary fibrosis
- coronavirus disease pulmonary fibrosis
- covid 19 outcome of hospitalization
- covid 19 risk factors
- challenges and futures pulmonary fibrosis
- treatment responses pulmonary fibrosis
- lung disease outcome of hospitalization
- molecular mechanisms pulmonary fibrosis
- covid 19 treatment responses
- covid 19 molecular mechanisms
- severe covid pulmonary fibrosis